Inventor
TAVERAS ARTHUR G
US65 patents
⚠️ This page may combine multiple inventors who share the name “TAVERAS ARTHUR G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
38 patentsUS5874442AFeb 23, 1999
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP129 citations99
US6372747B1Apr 16, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP93 citations97
US6362188B1Mar 26, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP85 citations97
US6432959B1Aug 13, 2002
Inhibitors of farnesyl-protein transferase
SCHERING CORP75 citations96
US6387905B2May 14, 2002
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP59 citations96
US6228856B1May 8, 2001
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP60 citations96
US5721236AFeb 24, 1998
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP72 citations96
US5719148AFeb 17, 1998
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP92 citations96
US5696121ADec 9, 1997
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP50 citations96
US6576639B1Jun 10, 2003
Compounds for the inhibition of farnesyl protein transferase
SCHERING CORP23 citations93
US6214828B1Apr 10, 2001
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP22 citations93
US6124295ASep 26, 2000
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP47 citations93
US6071907AJun 6, 2000
Tricyclic compounds useful as FPT inhibitors
SCHERING CORP21 citations93
US6051582AApr 18, 2000
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP52 citations93
US6040305AMar 21, 2000
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP60 citations93
US5958940ASep 28, 1999
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
SCHERING CORP33 citations93
US5877177AMar 2, 1999
Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP31 citations93
US6878709B2Apr 12, 2005
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
SCHERING CORP20 citations92
US6365588B1Apr 2, 2002
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP22 citations92
US6242458B1Jun 5, 2001
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP25 citations92
US6075025AJun 13, 2000
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US5861395AJan 19, 1999
Compounds useful for inhibition of farnesyl proteins transferase
SCHERING CORP22 citations92
US5807853ASep 15, 1998
Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP18 citations92
US5728703AMar 17, 1998
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US7964646B2Jun 21, 2011
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SCHERING CORP10 citations82
US7947720B2May 24, 2011
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SCHERING CORP10 citations82
US6492381B1Dec 10, 2002
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP7 citations74
US6426352B1Jul 30, 2002
Sulfonamide inhibitors of farnesyl-protein transferase
SCHERING CORP10 citations74
US6143758ANov 7, 2000
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP6 citations74
US5985879ANov 16, 1999
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP9 citations74
US5965570AOct 12, 1999
Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
SCHERING CORP10 citations74
US5958890ASep 28, 1999
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP10 citations74
US5945429AAug 31, 1999
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP8 citations74
US6300338B1Oct 9, 2001
Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP1 citations63
US7338968B2Mar 4, 2008
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
SCHERING CORP4 citations62
US7326729B2Feb 5, 2008
CXCR1 and CXCR2 chemokine antagonists
SCHERING CORP6 citations62
US6740661B2May 25, 2004
Farnesyl protein transferase inhibitors
SCHERING CORP2 citations62
US5977128ANov 2, 1999
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP2 citations62
BIOGEN MA INC
6 patentsUS9186367B2Nov 17, 2015
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC15 citations91
US10166250B2Jan 1, 2019
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC9 citations84
US9827258B2Nov 28, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC8 citations84
US9572824B2Feb 21, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC10 citations84
US9850206B2Dec 26, 2017
S1P and/or ATX modulating agents
BIOGEN MA INC4 citations73
US9771326B2Sep 26, 2017
S1P and/or ATX modulating agents
BIOGEN MA INC6 citations73
PHARMACOPEIA DRUG DISCOVERY
2 patentsBIOGEN IDEC INC
2 patentsTHOMAS JERMAINE
1 patentSCHERING CORPORATIONM
1 patentShowing the top 50 of 65 patents by PatentIndex Score.